Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Bethany T. Samuelson Bannow"'
Publikováno v:
Thrombosis Update, Vol 5, Iss , Pp 100088- (2021)
Women of childbearing potential have a high prevalence of venous thromboembolism (VTE) due to high estrogen states, such as pregnancy and the use of estrogen-containing contraceptives. Abnormal uterine bleeding (AUB) affects up to two-thirds of menst
Externí odkaz:
https://doaj.org/article/4fcb07f41b7744fc8538f97d09905f5f
Publikováno v:
Blood.
Excessive bleeding is relatively common in adult inpatients, whether as the primary reason for admission or developing during the hospital stay. Common causes include structural issues, medication effects and systemic illnesses but occasionally unexp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::266fbde56f4f4ade60235e68f2245e3f
https://doi.org/10.1182/blood.2021014766
https://doi.org/10.1182/blood.2021014766
Publikováno v:
Hematology. 2020:538-541
Up to two-thirds of menstruating women experience abnormal uterine bleeding (AUB) when treated with oral anticoagulants. However, the true prevalence of AUB for specific agents remains uncertain, as many of these episodes, while interfering significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ca857f787ab10dd04241743978772f3
https://doi.org/10.1182/hematology.2020000166
https://doi.org/10.1182/hematology.2020000166
Publikováno v:
Thrombosis Update, Vol 5, Iss, Pp 100088-(2021)
Women of childbearing potential have a high prevalence of venous thromboembolism (VTE) due to high estrogen states, such as pregnancy and the use of estrogen-containing contraceptives. Abnormal uterine bleeding (AUB) affects up to two-thirds of menst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed73c2b03bdea9c533513bde666778f7
http://www.sciencedirect.com/science/article/pii/S2666572721000572
http://www.sciencedirect.com/science/article/pii/S2666572721000572
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Abnormal or excessive menstrual bleeding affects one‐third of reproductive‐aged women. This number increases to 70% among women on direct oral anticoagulants (DOACs). While there is some variation in frequency of heavy menstrual bleeding (HMB) wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00ef508cf68cc92a1523d9247f0eb3b
http://europepmc.org/articles/PMC8326079
http://europepmc.org/articles/PMC8326079
Autor:
Michael Recht, Bethany T. Samuelson Bannow, Robert Klamroth, Cedric Hermans, Erik Berntorp, Claude Negrier, Tadashi Matsushita, Maria Elisa Mancuso, Jamie O'Hara, Elena Santagostino, Craig M. Kessler, Hermann Eichler
Publikováno v:
Blood reviews, Vol. 35, p. 43-50 (2019)
Factor VIII protein (FVIII) as a coagulation replacement factor has for decades been used as the standard of care for management of people with haemophilia A. It is effective for treatment of bleeding events, as prophylaxis to prevent bleeding events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a82cf96768fce0b9c61654c79a854c2
https://doi.org/10.1016/j.blre.2019.03.002
https://doi.org/10.1016/j.blre.2019.03.002
Publikováno v:
Blood and Marrow Transplant Handbook ISBN: 9783030536251
Patients undergoing hematopoietic cell transplant (HCT) are at risk for both arterial and venous thrombosis, similar to patients with solid organ malignancies, as well as for increased bleeding. Use of anticoagulant and antiplatelet agents in this po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea086ac8464662b2842efa9cefc9b34f
https://doi.org/10.1007/978-3-030-53626-8_13
https://doi.org/10.1007/978-3-030-53626-8_13
Publikováno v:
Hematology Am Soc Hematol Educ Program
Up to two-thirds of menstruating women experience abnormal uterine bleeding (AUB) when treated with oral anticoagulants. However, the true prevalence of AUB for specific agents remains uncertain, as many of these episodes, while interfering significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73ab438f5900a9e1a044109288d8aaa7
https://pubmed.ncbi.nlm.nih.gov/33275697
https://pubmed.ncbi.nlm.nih.gov/33275697
Autor:
Bethany T. Samuelson Bannow
Publikováno v:
Hematology Am Soc Hematol Educ Program
Heavy menstrual bleeding (HMB) is a common complication of anticoagulation, affecting ∼70% of menstruating women receiving oral anticoagulants. The risk of HMB is lower with apixaban and/or dabigatran than with rivaroxaban. HMB can result in iron d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1496cd5349edec861b75331ed47db53d
https://europepmc.org/articles/PMC7727540/
https://europepmc.org/articles/PMC7727540/
Autor:
Maureen K. Baldwin, Vivia Chi, Paul Sochacki, Alison Edelman, Bethany T. Samuelson Bannow, Owen J. T. McCarty
Publikováno v:
Thromb Res
Background Although heavy menstrual bleeding (HMB) is a known complication of anticoagulant therapy, rates of HMB in users of the direct oral anticoagulants (OACs) apixaban and rivaroxaban are largely unknown. Methods We performed a retrospective coh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b7c0f795209a6bac1f8aceea36395c
https://europepmc.org/articles/PMC7775335/
https://europepmc.org/articles/PMC7775335/